The arrival of Retatrutide ZPHC, at a concentration of 120mg, is sparking considerable excitement within the weight loss community. This groundbreaking dual GIP and GLP-1 target medication suggests to deliver significant improvements in fat loss compared to existing therapies. Initial clinical st